Rabies virus glycoprotein expression in Drosophila S2 cells: Influence of re-selection on protein expression

被引:3
作者
Dos Santos, Alexandra Souza [1 ]
Lemos, Marcos Alexandre Nobre [1 ]
Pereira, Carlos Augusto [1 ]
Jorge, Soraia Attie Calil [1 ]
机构
[1] Laboratório de Imunologia Viral, Instituto Butantan, São Paulo
关键词
Hygromycin re-selection; RVGP; S2; cells;
D O I
10.1002/biot.200900123
中图分类号
学科分类号
摘要
The aim of this study was to achieve expression of recombinant rabies virus glycoprotein (rRVGP) in Drosophila S2 cells. For this, a cDNA coding for the selection hygromycin antibiotic and the cDNA encoding the RVGP protein under the control of the constitutive actin promoter (Ac) were cloned in an expression plasmid, which was transfected into S2 cells. S2 cell populations (S2AcRVGPHy) showed rRVGP expression in cell lysates, attaining concentrations up to 1.5 μg/107 cells (705 μg/L). Of the transfected cells, 20% were shown to express the rRVGP. Cell subpopulations selected by limiting dilution expressed higher rRVGP yields and 90% of the cells were shown to express the rRVGP. Cell populations re-selected by addition of hygromycin were shown to express 10 times higher rRVGP yields. The data presented here show that Drosophila S2 cells can be efficiently transfected with an expression/selection plasmid for rRVGP expression, allowing its synthesis with a high degree of physical and biological integrity. The importance of subpopulation selection was indicated by the increasing rRVGP yields during these procedures. © 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
引用
收藏
页码:1578 / 1581
页数:3
相关论文
共 16 条
  • [1] Warrell M.J., Warrell D.A., Rabies and other lyssavirus diseases, Lancet, 363, pp. 959-969, (2004)
  • [2] Pastoret P.P., Brochier B., Aguilar-Setin A., Blancou J., Vaccination against rabies, Veterinary Vaccinology, (1997)
  • [3] Rath A., Choudhury S., Batra D., Kapre S.V., Et al., Relevance of the trans-membrane domain of the glycoprotein in generating an antibody response, Virus Res, 113, pp. 143-152, (2005)
  • [4] Wiktor T.J., Macfarlan R.I., Reagan K.J., Dietzschold B., Et al., Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene, Proc. Natl. Acad. Sci. USA, 81, pp. 7194-7198, (1984)
  • [5] Lodmell D.L., Esposito J.J., Ewalt L.C., Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: Considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals, Vaccine, 22, pp. 3329-3333, (2004)
  • [6] Prehaud C., Coulon P., Diallo A., Martinet-Edelist C., Flamand A., Characterization of a new temperature-sensitive and avirulent mutant of the rabies virus, J. Gen. Virol, 70, pp. 133-143, (1989)
  • [7] Tordo N., Kouknetzoff A., The rabies virus genome: An overview, Onderstepoort J. Vet. Res, 60, pp. 263-269, (1993)
  • [8] Schneider I., Cell lines derived from late embryonic stages of Drosophila melanogaster, J. Embryol. Exp. Morphol, 27, pp. 353-365, (1972)
  • [9] Ivey-Hoyle M., Recombinant gene expression in cultured Drosophila melanogaster cells, Curr. Opin. Biotechnol, 2, pp. 704-707, (1991)
  • [10] Ikonomou L., Schneider Y.J., Agathos S.N., Insect cell culture for industrial production of recombinant proteins, Appl. Microbiol. Biotechnol, 62, pp. 1-20, (2003)